Delivery Order SPE2DR25D3103-SPE2DR26F9M97
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $117,002.57 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price contract structure. The award, issued on December 1, 2025, is scheduled for completion by December 2, 2025, and represents a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract value of $2,049.36. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $14,034.53 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $16,498.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on November 12, 2025, with completion expected by November 13, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement to support military healthcare operations. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,789.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $15,593.79 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract valued at $25,599.93, with an ultimate completion date of July 15, 2025. This non-set-aside, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,139.70 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-set-aside, competitively awarded contract carries a firm fixed price and an ultimate completion date of December 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The delivery order operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $56,984.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 13, 2025, with completion targeted for November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- The Defense Logistics Agency awarded a $16,728.21 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 5, 2025, with performance fulfillment from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9M97Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,711.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications including brand-name and generic drugs to support military healthcare programs and federal medical procurement needs. The Eliquis order supports the Defense Health Agency and other government healthcare systems requiring anticoagulant therapy for eligible beneficiaries across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 12/8/25 |